trait,umbrella,umbrella_agreement,umbrella_flag,category,category_agreement,category_flag
alk fusion,ALK Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
alk fusion status,ALK Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
alk gene translocation status,ALK Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
alk mutation,ALK Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
alk rearrangement,ALK Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
alk status,ALK Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
alk translocation,ALK Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
ast/alt,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
ability to safely receive investigational and soc regimens,Treatment Amenability,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
ability to swallow oral medication,Gastrointestinal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
absence of identifiable primary tumor or nodal disease,Primary Tumor Characteristics,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
absolute neutrophil count,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
actionable mutations,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
active infection,Active Infection,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
active infections,Active Infection,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
active tuberculosis,Tuberculosis,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
acute coronary syndrome,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
acute disease,Intercurrent Illness,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
additional malignancy,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
adenocarcinoma or undifferentiated carcinoma histology,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
adjuvant chemotherapy tolerance,Treatment-Related Toxicity,2/5,ðŸ”´,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
adjuvant/neoadjuvant therapy,Adjuvant/Neoadjuvant Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
advanced refractory solid tumors,Advanced/Refractory Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
age,Age,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
age 18-75 years,Age,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
age â‰¥18 years,Age,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
allogeneic transplant,Transplant History,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
alpha-fetoprotein level,Tumor Markers,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
amenability to consolidation immunotherapy,Treatment Amenability,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
anti-hepatitis b core antibody,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
anticoagulant treatment,Anticoagulation Therapy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
anticoagulation treatment,Anticoagulation Therapy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
arterial thrombotic events,Thrombotic Events,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
autoimmune disease,Autoimmune Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
autoimmune disease or immune deficiency,Autoimmune Disease,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
autoimmune diseases,Autoimmune Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
autoimmune disorder,Autoimmune Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
autoimmune disorders,Autoimmune Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
autoimmune/inflammatory disorders,Autoimmune Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
bevacizumab treatment continuity,Prior Anti-VEGF Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
bilirubin,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
bleeding disorders,Bleeding/Coagulation Disorders,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
blood pressure control,Blood Pressure/Hypertension,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
body weight,Body Weight and Nutritional Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
brain mri or ct prior to registration,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
brain imaging,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
brain metastases,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
cns metastases,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
copd with respiratory failure,Pulmonary Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
crt sequence,Prior Chemoradiation,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
ct chest with iv contrast or pet/ct,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
cyp3a4 inhibitors/inducers,Drug Interactions,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
carcinomatous meningitis,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
cardiac aneurysms,Cardiac Function,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cardiac conditions,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cardiac disease,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cardiac disease history,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cardiac function,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cardiovascular disease,Cardiac Function,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
centrally located primary tumor <2 cm from nodal disease (overlap risk),Primary Tumor Characteristics,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
chemotherapy cycles,Prior Chemotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
chemotherapy timing,Treatment Timing,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
child-pugh classification,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
chronic immunosuppression,Immunosuppression/Immunodeficiency,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
cisplatin-based chemotherapy,Prior Chemotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
coagulation disorders,Bleeding/Coagulation Disorders,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
complete resection,Surgical Resectability/Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
concurrent hbv/hcv,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
concurrent anti-cancer therapy,Concurrent Anti-Cancer Therapy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
concurrent antineoplastic therapy,Concurrent Anti-Cancer Therapy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
concurrent clinical trials,Investigational Study Participation,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,2/5,ðŸ”´
concurrent/prior malignancy,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
consent compliance,Study Compliance,3/5,ðŸŸ¡,NOT_PREDICTABLE,3/5,ðŸŸ¡
contraception,Contraception Requirements,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
contraception compliance,Contraception Requirements,4/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
contraceptive use,Contraception Requirements,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
contraceptive use compliance,Contraception Requirements,4/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
creatinine clearance,Renal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
creatinine clearance â‰¥25 ml/min (cockcroft-gault),Renal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
curative intent eligibility (clinical appropriateness),Treatment Amenability,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
denosumab use,Specific Prior Treatment Agents,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
diabetes,Diabetes,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
diagnosis,Diagnosis Confirmation,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
disease progression,Disease Progression,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
disease progression after anti-pd-1/pd-l1,Disease Progression,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
disease progression after neoadjuvant/adjuvant/consolidation anti-pd-1/pd-l1,Disease Progression,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
disease progression status,Disease Progression,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
disease recurrence timing,Disease Recurrence,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
drug allergy history,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
drug hypersensitivity,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
drug intolerance,Drug Hypersensitivity/Allergy,2/5,ðŸ”´,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
ebv infection,EBV Infection,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
ecg abnormalities,ECG Abnormalities,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
ecog ps,Performance Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
ecog performance status,Performance Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
ecog performance status 0-2,Performance Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
egfr tki treatment failure,Prior Targeted Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
egfr mutation,EGFR Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
egfr mutation status,EGFR Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
egfr status,EGFR Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
egfr/alk status,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
echocardiogram findings,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
end-organ function,Organ Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
epstein-barr virus (ebv) infection,EBV Infection,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
expected survival,Life Expectancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
extracapsular extension,Primary Tumor Characteristics,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
female contraception compliance,Contraception Requirements,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
female pregnancy status,Pregnancy/Lactation Status,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
genetic informed consent,Informed Consent,3/5,ðŸŸ¡,NOT_PREDICTABLE,4/5,ðŸŸ¢
germline sequencing,Genetic/Germline Testing,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
grade 3 active infection,Active Infection,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
grade â‰¥2 pneumonitis from prior crt,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
gross disease remaining,Residual Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
hbv infection,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hbv status,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hcc diagnosis,Diagnosis Confirmation,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
hcv infection,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hcv status,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
her2 status,HER2 Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
hiv infection,HIV Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hiv status,HIV Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hematologic function,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hematologic function amenable to chemo/radiation,Hematologic Function,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hematological function,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hemoglobin,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hemoglobin level,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hemoptysis history,Bleeding/Coagulation Disorders,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
hepatic disorder,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hepatitis b surface antigen,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hepatitis status,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
histology,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
histology exclusion,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
hypersensitivity,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
hypersensitivity to carboplatin or nab-paclitaxel,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
hypersensitivity to monoclonal antibodies,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
ild,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
ild/pneumonitis,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
inr,Bleeding/Coagulation Disorders,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
identified primary tumor and at least one nodal metastasis,Primary Tumor Characteristics,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
idiopathic pulmonary fibrosis/pneumonitis,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
imaging timing,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
immune-mediated therapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
immunocompromised state,Immunosuppression/Immunodeficiency,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
immunostimulatory agents,Concurrent Anti-Cancer Therapy,2/5,ðŸ”´,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
immunosuppressive medication,Immunosuppression/Immunodeficiency,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
immunosuppressive therapy,Immunosuppression/Immunodeficiency,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
infection,Active Infection,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
inflammatory bowel disease,Autoimmune Disease,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
informed consent,Informed Consent,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
inoperability status,Surgical Resectability/Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
interstitial lung disease,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
interstitial lung disease/pneumonitis,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
investigational study participation,Investigational Study Participation,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,2/5,ðŸ”´
investigational therapy,Investigational Study Participation,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,2/5,ðŸ”´
investigator discretion,Investigator Assessment,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
investigator judgment,Investigator Assessment,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
investigator judgment early termination risk,Investigator Assessment,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
keap1 mutation,KRAS/STK11/KEAP1 Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
kras mutation,KRAS/STK11/KEAP1 Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
kaposi sarcoma/mcd in hiv,Prior/Concurrent Malignancy,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
known egfr/alk/other driver mutation,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
known pd-l1 result,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
lab abnormalities,Organ Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
left ventricular ejection fraction,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
leptomeningeal carcinomatosis,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
life expectancy,Life Expectancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
life-threatening non-cancer illness,Intercurrent Illness,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
live attenuated vaccination,Live Vaccination,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
live vaccination,Live Vaccination,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
live vaccine,Live Vaccination,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
liver enzymes,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
liver function,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
mds/aml,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
mrd status,MRD Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
maintenance therapy history,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
major surgery,Prior Surgery,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
malabsorption syndromes,Gastrointestinal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
male contraception,Contraception Requirements,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
male contraception compliance,Contraception Requirements,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
measurable disease,Measurable Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
medical/psychiatric conditions,Neurological/Psychiatric Conditions,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
metastatic disease,Metastatic Disease Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
metastatic or locally recurrent gastro-oesophageal cancer,Metastatic Disease Status,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
minimal pleural effusion eligibility,Pleural/Pericardial Effusion,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
mixed histology,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
mixed tumor histology,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
monoclonal antibody hypersensitivity,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
n2 node sampling,Mediastinal/Lymph Node Staging,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
nsclc histology,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
nsclc histology/cytology confirmation,Diagnosis Confirmation,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
nsclc resection status,Surgical Resectability/Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
nsclc stage,Disease Stage,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
negative pregnancy test within 14 days,Pregnancy/Lactation Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
neoadjuvant radiotherapy,Prior Radiotherapy,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
neoadjuvant/adjuvant therapy history,Adjuvant/Neoadjuvant Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
neurological/psychiatric disorders,Neurological/Psychiatric Conditions,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
no egfr mutation or alk fusion,Actionable Genomic Alterations,3/5,ðŸŸ¡,NOT_PREDICTABLE,5/5,ðŸŸ¢
no evidence of stage iv,Disease Stage,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
no evidence of distant metastases (by fdg pet/ct),Metastatic Disease Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
non-healing wounds,Wound Healing,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
non-malignant pleural effusion status,Pleural/Pericardial Effusion,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
non-squamous nsclc histology,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
nucleoside analog treatment,Specific Prior Treatment Agents,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
organ and marrow function,Organ Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
organ function,Organ Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
organ transplant,Transplant History,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
other active malignancy,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
other driver oncogenes,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
other malignancy,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
other primary malignancy,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
pd-1/pd-l1 expression,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pd-l1 biomarker,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pd-l1 expression,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pd-l1 status,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pd-l1 status exclusion,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pd-l1 testing,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pd-l1 tissue,PD-L1 Expression Status,4/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pet-ct timing,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
pet/ct staging,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
"pathologically proven non-operable stage iib or iii, node positive nsclc",Disease Stage,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
performance status,Performance Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
pericardial effusion,Pleural/Pericardial Effusion,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
platelet count,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
platelets,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
platinum allergy,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
platinum doublet contraindication,Treatment Contraindications,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
platinum doublet cycles,Prior Chemotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
platinum doublet progression,Disease Progression,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
platinum-based chemotherapy contraindication,Treatment Contraindications,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
pleural fluid cytology if effusion visible on ct and x-ray,Pleural/Pericardial Effusion,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
pneumonitis,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
pneumonitis history,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
pneumonitis/ild,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
positive microscopic margins,Residual Disease,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
post-op chest ct,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
post-op recurrence,Disease Recurrence,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
pre-op fdg-pet/ct,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
pre-op chest ct/mri,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
pre-op imaging coverage,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
pre-op mediastinal staging,Mediastinal/Lymph Node Staging,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
pre-surgical plasma sample,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
pregnancy or unwillingness to discontinue nursing,Pregnancy/Lactation Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
pregnancy status,Pregnancy/Lactation Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
pregnancy test,Pregnancy/Lactation Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
pregnancy/breastfeeding status,Pregnancy/Lactation Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
pregnancy/lactation status,Pregnancy/Lactation Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
previous malignancies,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
primary immunodeficiency,Immunosuppression/Immunodeficiency,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
primary tumor site,Primary Tumor Characteristics,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
primary tumor size â‰¤7 cm,Primary Tumor Characteristics,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
prior nsclc therapy,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior parp inhibitor,Prior Targeted Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior pd-1/pd-l1 treatment,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior stage iii therapy,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior tki/crizotinib treatment,Prior Targeted Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior adjuvant therapy,Adjuvant/Neoadjuvant Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
prior anti-pd-1/pd-l1,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior anti-pd-1/pd-l1 therapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior anti-tigit therapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior anti-vegf therapy,Prior Anti-VEGF Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior anti-cancer therapy lines,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior bevacizumab plus platinum doublet treatment,Prior Anti-VEGF Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior checkpoint inhibitor,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior checkpoint inhibitor use,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior checkpoint therapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior chemoradiation,Prior Chemoradiation,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior high-dose chemotherapy,Prior Chemotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior immune-mediated therapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior immunotherapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior lung radiation,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior neoadjuvant therapy,Adjuvant/Neoadjuvant Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
prior or concurrent malignancy not interfering with trial,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
prior platinum-based therapy,Prior Chemotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior radiotherapy to the study cancer,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior sorafenib treatment,Prior Targeted Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior systemic therapy,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior systemic therapy for current cancer,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior systemic treatment,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior systemic treatment history,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior targeted therapy for sensitizing mutation,Prior Targeted Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior therapy,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior therapy lines,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior thoracic radiotherapy,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior trastuzumab treatment,Specific Prior Treatment Agents,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
prior treatment,Prior Systemic Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
progression during crt,Disease Progression,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
proteinuria,Proteinuria,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
psychotropic drug or alcohol abuse,Neurological/Psychiatric Conditions,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
pulmonary conditions,Pulmonary Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
pulmonary fibrosis/pneumonitis,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
pulmonary function,Pulmonary Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
pulmonary interstitial fibrosis,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
recist 1.1 evaluable disease by ct scan,Measurable Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
recist evaluable lesions,Measurable Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
recist v1.1 measurable disease,Measurable Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
ros1 rearrangement,ROS1 Rearrangement Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
radiation dose,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
radiation therapy,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
re-resection status,Surgical Resectability/Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
recent biological response modifiers,Prior Immunotherapy/Checkpoint Inhibitors,2/5,ðŸ”´,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
recent bleeding events,Bleeding/Coagulation Disorders,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
recent drug therapy,Prior Systemic Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
recent investigational treatment,Investigational Study Participation,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,2/5,ðŸ”´
recent radiotherapy,Prior Radiotherapy,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
recent surgery,Prior Surgery,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
recent systemic therapy,Prior Systemic Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
recurrent or refractory nsclc,Advanced/Refractory Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
renal function,Renal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
resection type,Surgical Resectability/Status,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
residency and ancestry,Residency/Demographics,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
stk11 mutation,KRAS/STK11/KEAP1 Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
second malignancy history,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
second-line therapy refusal,Treatment Amenability,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
seizure disorder,Neurological/Psychiatric Conditions,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
sensitizing egfr mutation,EGFR Mutation Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
separate tumor nodules in same lobe,Primary Tumor Characteristics,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
serum albumin,Body Weight and Nutritional Status,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
serum bilirubin,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
serum creatinine,Renal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
serum total bilirubin,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
severe cardiac disease,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
severe infection,Active Infection,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
severe infections,Active Infection,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
sex,Sex,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
small cell histology,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
small cell lung cancer,Tumor Histology,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
smoking status,Smoking Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
spinal cord compression,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
stage,Disease Stage,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
stage iiib upstaging,Disease Stage,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
staging system,Disease Stage,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
steroid use,Corticosteroid Use,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
study compliance willingness,Study Compliance,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
surgery recovery,Prior Surgery,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
surgical candidacy,Surgical Resectability/Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
surgical candidate,Surgical Resectability/Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
surgical eligibility,Surgical Resectability/Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
surgical margins,Surgical Resectability/Status,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
surgical resectability/inoperability/refusal,Surgical Resectability/Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
systemic corticosteroids,Corticosteroid Use,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
systemic disease,Metastatic Disease Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
systemic infection,Active Infection,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
tace eligibility,Locoregional Therapy Eligibility,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
tki treatment,Prior Targeted Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
tnm staging iiib/iiic/iv,Disease Stage,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
target lesion,Measurable Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
thyroid function,Thyroid Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
time from progression to randomization,Treatment Timing,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
toxicity,Treatment-Related Toxicity,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
toxicity from prior therapy,Treatment-Related Toxicity,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
toxicity recovery,Treatment-Related Toxicity,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
treatment start feasibility,Treatment Timing,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
tuberculosis,Tuberculosis,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
tumor sample,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
tumor tissue,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
tumor tissue and blood samples,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
tumor tissue provision,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
tumor tissue sample,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
uncontrolled illness,Intercurrent Illness,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
uncontrolled intercurrent illness,Intercurrent Illness,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
unresectable/metastatic disease,Advanced/Refractory Disease,2/5,ðŸ”´,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
vascular aneurysms,Vascular Conditions,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
venous thrombotic events,Thrombotic Events,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
viral hepatitis status,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
viral load,Hepatitis B/C Status,2/5,ðŸ”´,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
who performance status,Performance Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
wedge resection,Surgical Resectability/Status,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
weight loss,Body Weight and Nutritional Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
whole blood transfusion,Transfusion Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
wound healing,Wound Healing,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
actionable driver oncogenes,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
actionable genomic alterations,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
actionable molecular alterations,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
active second malignancy,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
adhesive allergy,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
adjuvant chemotherapy,Adjuvant/Neoadjuvant Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
adjuvant neoadjuvant timing,Treatment Timing,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
adjuvant progression timing,Disease Progression,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
adjuvant radiotherapy,Adjuvant/Neoadjuvant Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
adjuvant therapy,Adjuvant/Neoadjuvant Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
alkaline phosphatase,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
anc,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
arrhythmia history,Cardiac Function,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
ast alt,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
autoimmune inflammatory disorder,Autoimmune Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
biosample provision,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
blood pressure,Blood Pressure/Hypertension,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
bone marrow function,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
cardiac history,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cardiovascular cerebrovascular condition,Cardiac Function,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cardiovascular history,Cardiac Function,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cardiovascular impairment,Cardiac Function,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
cerebrovascular accident,Vascular Conditions,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
chemotherapy recovery,Treatment-Related Toxicity,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
chronic steroid use,Corticosteroid Use,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
clinical study participation,Investigational Study Participation,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,2/5,ðŸ”´
cns lesions,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
compliance,Study Compliance,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
concurrent anticancer therapy,Concurrent Anti-Cancer Therapy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
concurrent experimental therapy,Investigational Study Participation,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,2/5,ðŸ”´
concurrent investigational therapy,Investigational Study Participation,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,2/5,ðŸ”´
corneal disease,Corneal Disease,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
ct scan,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
curative intent therapy,Treatment Amenability,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
current pulmonary conditions,Pulmonary Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
device operation,Implantable Devices,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
disease burden,Measurable Disease,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
disease response,Disease Progression,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
dlco,Pulmonary Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
docetaxel contraindication,Treatment Contraindications,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
drug allergy,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
early stage relapse,Disease Recurrence,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
egfr alk braf ros1 mutation,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
egfr alk mutation,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
egfr alk ros1,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
egfr alk ros1 testing,Actionable Genomic Alterations,4/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
egfr alk status,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
egfr ros1 alk,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
enrollment timing,Treatment Timing,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
fdg pet ct,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
female contraception,Contraception Requirements,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
fistula,Wound Healing,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
follow up accessibility,Study Compliance,4/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
gi abnormalities,Gastrointestinal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
gi absorption condition,Gastrointestinal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
gi disease,Gastrointestinal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
hbv hcv infection,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hematological dysfunction,Hematologic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hemoptysis,Bleeding/Coagulation Disorders,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
hepatic dysfunction,Hepatic Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
hepatitis b c,Hepatitis B/C Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
high dose steroid,Corticosteroid Use,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
hypertension,Blood Pressure/Hypertension,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
ibd gi perforation,Gastrointestinal Function,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
ild history,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
ild pneumonitis,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
ild pneumonitis history,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
immunodeficiency,Immunosuppression/Immunodeficiency,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
immunodeficiency immunosuppression,Immunosuppression/Immunodeficiency,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
immunodeficiency transplant immunosuppression,Immunosuppression/Immunodeficiency,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
immunosuppressive drugs,Immunosuppression/Immunodeficiency,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
immunotherapy contraindication,Treatment Contraindications,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
immunotherapy hypersensitivity,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
implantable devices,Implantable Devices,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
infection status,Active Infection,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
institutionalization,Study Compliance,2/5,ðŸ”´,NOT_PREDICTABLE,3/5,ðŸŸ¡
intercurrent illness,Intercurrent Illness,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
interference condition,Intercurrent Illness,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
ip hypersensitivity,Drug Hypersensitivity/Allergy,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
leptomeningeal cns disease,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
leptomeningeal disease,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
live virus vaccination,Live Vaccination,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
lvef,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
major surgery recovery,Prior Surgery,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
mds aml history,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
measurable lesion,Measurable Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
medical psychiatric risk,Neurological/Psychiatric Conditions,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
metastatic progression timing,Disease Progression,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
minor surgery,Prior Surgery,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
molecular alterations,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
molecular status,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
mrd eligibility,MRD Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
neo adjuvant chemotherapy,Adjuvant/Neoadjuvant Therapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
other actionable alterations,Actionable Genomic Alterations,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
other malignancy history,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
palliative radiotherapy,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
pd l1 expression,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pd l1 status,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pd l1 tps,PD-L1 Expression Status,5/5,ðŸŸ¢,NOT_PREDICTABLE,5/5,ðŸŸ¢
pembrolizumab monotherapy,Prior Immunotherapy/Checkpoint Inhibitors,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
pericarditis history,Cardiac Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
peripheral neuropathy,Neurological/Psychiatric Conditions,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
persistent disease,Residual Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
pet mri brain,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
physician assigned therapy,Investigator Assessment,4/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
planned surgery,Prior Surgery,3/5,ðŸŸ¡,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
platinum cycles,Prior Chemotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
pneumonitis ild,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
post platinum therapy,Prior Chemotherapy,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
post treatment imaging,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
pregnancy breastfeeding,Pregnancy/Lactation Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
pregnancy intent,Contraception Requirements,3/5,ðŸŸ¡,NOT_PREDICTABLE,3/5,ðŸŸ¡
pregnancy lactation,Pregnancy/Lactation Status,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
preop imaging,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
preop radiotherapy,Prior Radiotherapy,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior adjuvant pd l1,Prior Immunotherapy/Checkpoint Inhibitors,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior brain mets,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior crt,Prior Chemoradiation,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior definitive therapy,Prior Systemic Therapy,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior immune related ae,Treatment-Related Toxicity,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
prior immune therapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior induction therapy,Prior Systemic Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior io agent,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior io rtki therapy,Prior Immunotherapy/Checkpoint Inhibitors,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior io therapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior kras g12c inhibitor,Prior Targeted Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior lung radiotherapy,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior mmae ib6 therapy,Specific Prior Treatment Agents,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
prior pd1 pdl1 therapy,Prior Immunotherapy/Checkpoint Inhibitors,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior pneumonitis,Interstitial Lung Disease/Pneumonitis,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
prior radiotherapy,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
prior topoisomerase adc,Specific Prior Treatment Agents,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
prior toxicity,Treatment-Related Toxicity,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
prior transplant,Transplant History,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
prior transplantation,Transplant History,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
psychiatric condition,Neurological/Psychiatric Conditions,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
pulmonary compromise,Pulmonary Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
pulmonary disease,Pulmonary Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
qtcf interval,ECG Abnormalities,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
questionnaire completion,Study Compliance,5/5,ðŸŸ¢,NOT_PREDICTABLE,3/5,ðŸŸ¡
radiation technique,Prior Radiotherapy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
recent antitumor therapy,Prior Systemic Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
recent colony stimulating factor,Prior Systemic Therapy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
recent mri brain,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
recent pet,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
recent steroids,Corticosteroid Use,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
recovery from prior therapy,Treatment-Related Toxicity,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
renal dysfunction,Renal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,5/5,ðŸŸ¢
resection types,Surgical Resectability/Status,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
residual disease site,Residual Disease,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
second malignancy,Prior/Concurrent Malignancy,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
second screen imaging,Imaging Requirements,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
sequential crt,Prior Chemoradiation,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
small cell sarcomatoid,Tumor Histology,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
stable brain mets,Brain/CNS Metastases,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
surgical resection,Surgical Resectability/Status,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
surveillance consent,Informed Consent,4/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
surveillance start timing,Treatment Timing,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
swallowing ability,Gastrointestinal Function,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
synchronous tumors,Prior/Concurrent Malignancy,3/5,ðŸŸ¡,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
systemic therapy timing,Treatment Timing,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
third space fluid retention,Pleural/Pericardial Effusion,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,3/5,ðŸŸ¡
tissue provision,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
treatment start,Treatment Timing,4/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
tumor biopsy,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
tumor cavitation vessel invasion,Primary Tumor Characteristics,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
tumor size number,Primary Tumor Characteristics,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
tumor specimen,Tumor Tissue/Biospecimen,5/5,ðŸŸ¢,NOT_PREDICTABLE,4/5,ðŸŸ¢
unapproved surgical procedures,Prior Surgery,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,3/5,ðŸŸ¡
unresectable nsclc,Surgical Resectability/Status,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
unresectable status,Surgical Resectability/Status,4/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,4/5,ðŸŸ¢
washout period,Washout Period,5/5,ðŸŸ¢,PREDICTABLE_BUT_NOT_NECESSARY,4/5,ðŸŸ¢
who ps,Performance Status,5/5,ðŸŸ¢,PREDICTABLE_AND_NECESSARY,5/5,ðŸŸ¢
